HOUSTON, Aug. 5, 2025 /PRNewswire/ -- Ottobock is proud to announce a strategic collaboration with Baylor College of Medicine's Orthotics &…
Announcement no. 33/2025 Interim report Q2 2025 22 July 2025 COPENHAGEN, Denmark, July 22, 2025 /PRNewswire/ -- Sveinn Sölvason, President…
IDE approval in both countries follows strong feasibility clinical results in France GRENOBLE, France and MINNEAPOLIS, July 17, 2025 /PRNewswire/…
Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access…
Companies will jointly develop niia™ signature, an all-in-one wearable insulin patch pump that provides integrated insulin delivery with real-time glucose…
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes…
Adam Kovalčík, 19, receives $100,000 Top Award for his development of a medicine that can stop viruses from copying genes…
DELRAY BEACH, Fla., May 14, 2025 /PRNewswire/ -- The global exoskeleton market is projected to grow from USD 0.56 billion in…
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16,…
Investment will accelerate clinical trials and commercialization of Phantom X, with Ottobock joining Phantom Neuro's Board of Directors AUSTIN, Texas,…